{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:01:48Z","timestamp":1776740508327,"version":"3.51.2"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00134-025-07903-3","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:49:52Z","timestamp":1748076592000},"page":"893-903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["How to approach a patient hospitalized for pneumonia who is not responding to treatment?"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-7304","authenticated-orcid":false,"given":"Pedro","family":"Povoa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-3624","authenticated-orcid":false,"given":"Lu\u00eds","family":"Coelho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-2563","authenticated-orcid":false,"given":"Jordi","family":"Carratala","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-0951","authenticated-orcid":false,"given":"Kelly","family":"Cawcutt","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-4331","authenticated-orcid":false,"given":"Sara E.","family":"Cosgrove","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-4747","authenticated-orcid":false,"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-5710","authenticated-orcid":false,"given":"Carlos A.","family":"Gomez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-4498","authenticated-orcid":false,"given":"Michael","family":"Klompas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-2212","authenticated-orcid":false,"given":"Thiago","family":"Lisboa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-0357","authenticated-orcid":false,"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-1453","authenticated-orcid":false,"given":"Jorge I. F.","family":"Salluh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3299-855X","authenticated-orcid":false,"given":"Sias","family":"Scherger","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-3528","authenticated-orcid":false,"given":"Daniel A.","family":"Sweeney","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-6294","authenticated-orcid":false,"given":"Andre C.","family":"Kalil","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"7903_CR1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323:1478\u20131487. https:\/\/doi.org\/10.1001\/jama.2020.2717","journal-title":"JAMA"},{"key":"7903_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2049936112469017","volume":"1","author":"J Goncalves-Pereira","year":"2013","unstructured":"Goncalves-Pereira J, Conceicao C, Povoa P (2013) Community-acquired pneumonia: identification and evaluation of nonresponders. Ther Adv Infect Dis 1:5\u201317. https:\/\/doi.org\/10.1177\/2049936112469017","journal-title":"Ther Adv Infect Dis"},{"key":"7903_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jama.279.18.1452","volume":"279","author":"EA Halm","year":"1998","unstructured":"Halm EA, Fine MJ, Marrie TJ et al (1998) Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 279:1452\u20131457. https:\/\/doi.org\/10.1001\/jama.279.18.1452","journal-title":"JAMA"},{"key":"7903_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1164\/ajrccm.162.1.9907023","volume":"162","author":"F Arancibia","year":"2000","unstructured":"Arancibia F, Ewig S, Martinez JA et al (2000) Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 162:154\u2013160. https:\/\/doi.org\/10.1164\/ajrccm.162.1.9907023","journal-title":"Am J Respir Crit Care Med"},{"key":"7903_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/archinte.164.5.502","volume":"164","author":"B Roson","year":"2004","unstructured":"Roson B, Carratala J, Fernandez-Sabe N et al (2004) Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 164:502\u2013508. https:\/\/doi.org\/10.1001\/archinte.164.5.502","journal-title":"Arch Intern Med"},{"key":"7903_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0043-1778139","volume":"45","author":"R Mendez","year":"2024","unstructured":"Mendez R, Gonzalez-Jimenez P, Mengot N et al (2024) Treatment failure and clinical stability in severe community-acquired pneumonia. Semin Respir Crit Care Med 45:225\u2013236. https:\/\/doi.org\/10.1055\/s-0043-1778139","journal-title":"Semin Respir Crit Care Med"},{"key":"7903_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/thx.2003.017756","volume":"59","author":"R Menendez","year":"2004","unstructured":"Menendez R, Torres A, Zalacain R et al (2004) Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 59:960\u2013965. https:\/\/doi.org\/10.1136\/thx.2003.017756","journal-title":"Thorax"},{"key":"7903_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-15-6","volume":"15","author":"F Blasi","year":"2014","unstructured":"Blasi F, Ostermann H, Racketa J et al (2014) Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Respir Res 15:6. https:\/\/doi.org\/10.1186\/1465-9921-15-6","journal-title":"Respir Res"},{"key":"7903_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00134-023-07210-9","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Reyes LF, Nseir S et al (2023) European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI. Intensive Care Med 49:1212\u20131222. https:\/\/doi.org\/10.1007\/s00134-023-07210-9","journal-title":"Intensive Care Med"},{"key":"7903_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00134-017-4962-2","volume":"44","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Montero JG, Paiva JA (2018) When antibiotic treatment fails. Intensive Care Med 44:73\u201375. https:\/\/doi.org\/10.1007\/s00134-017-4962-2","journal-title":"Intensive Care Med"},{"key":"7903_CR11","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by The infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"key":"7903_CR12","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"7903_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49:615\u2013632. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"7903_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1378\/chest.97.3.576","volume":"97","author":"A Ortqvist","year":"1990","unstructured":"Ortqvist A, Kalin M, Lejdeborn L et al (1990) Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest 97:576\u2013582. https:\/\/doi.org\/10.1378\/chest.97.3.576","journal-title":"Chest"},{"key":"7903_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/thx.2007.086785","volume":"63","author":"R Menendez","year":"2008","unstructured":"Menendez R, Cavalcanti M, Reyes S et al (2008) Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63:447\u2013452. https:\/\/doi.org\/10.1136\/thx.2007.086785","journal-title":"Thorax"},{"key":"7903_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13613-024-01323-0","volume":"14","author":"P Povoa","year":"2024","unstructured":"Povoa P, Coelho L, Cidade JP et al (2024) Biomarkers in pulmonary infections: a clinical approach. Ann Intensive Care 14:113. https:\/\/doi.org\/10.1186\/s13613-024-01323-0","journal-title":"Ann Intensive Care"},{"key":"7903_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/01.CCM.0000055380.86458.1E","volume":"31","author":"CM Luna","year":"2003","unstructured":"Luna CM, Blanzaco D, Niederman MS et al (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676\u2013682. https:\/\/doi.org\/10.1097\/01.CCM.0000055380.86458.1E","journal-title":"Crit Care Med"},{"key":"7903_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/01.CCM.0000249826.81273.E4","volume":"35","author":"A Combes","year":"2007","unstructured":"Combes A, Luyt CE, Fagon JY et al (2007) Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 35:146\u2013154. https:\/\/doi.org\/10.1097\/01.CCM.0000249826.81273.E4","journal-title":"Crit Care Med"},{"key":"7903_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1183\/09031936.05.00071704","volume":"25","author":"P Povoa","year":"2005","unstructured":"Povoa P, Coelho L, Almeida E et al (2005) C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 25:804\u2013812. https:\/\/doi.org\/10.1183\/09031936.05.00071704","journal-title":"Eur Respir J"},{"key":"7903_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jcrc.2017.07.021","volume":"42","author":"L Rabello","year":"2017","unstructured":"Rabello L, Povoa P, Lapa ESJR et al (2017) Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer. J Crit Care 42:231\u2013237. https:\/\/doi.org\/10.1016\/j.jcrc.2017.07.021","journal-title":"J Crit Care"},{"key":"7903_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","volume":"49","author":"P Povoa","year":"2023","unstructured":"Povoa P, Coelho L, Dal-Pizzol F et al (2023) How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 49:142\u2013153. https:\/\/doi.org\/10.1007\/s00134-022-06956-y","journal-title":"Intensive Care Med"},{"key":"7903_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcrc.2017.05.007","volume":"41","author":"P Povoa","year":"2017","unstructured":"Povoa P, Martin-Loeches I, Ramirez P et al (2017) Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study. J Crit Care 41:91\u201397. https:\/\/doi.org\/10.1016\/j.jcrc.2017.05.007","journal-title":"J Crit Care"},{"key":"7903_CR23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","volume":"163","author":"PJ Dennesen","year":"2001","unstructured":"Dennesen PJ, van der Ven AJ, Kessels AG et al (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371\u20131375. https:\/\/doi.org\/10.1164\/ajrccm.163.6.2007020","journal-title":"Am J Respir Crit Care Med"},{"key":"7903_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1164\/ajrccm\/147.1.38","volume":"147","author":"P Montravers","year":"1993","unstructured":"Montravers P, Fagon JY, Chastre J et al (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147:38\u201344. https:\/\/doi.org\/10.1164\/ajrccm\/147.1.38","journal-title":"Am Rev Respir Dis"},{"key":"7903_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59020199","author":"L Coelho","year":"2023","unstructured":"Coelho L, Moniz P, Guerreiro G et al (2023) Airway and respiratory devices in the prevention of ventilator-associated pneumonia. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59020199","journal-title":"Medicina (Kaunas)"},{"key":"7903_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2217\/fmb-2016-0040","volume":"11","author":"L Fernandez-Barat","year":"2016","unstructured":"Fernandez-Barat L, Torres A (2016) Biofilms in ventilator-associated pneumonia. Future Microbiol 11:1599\u20131610. https:\/\/doi.org\/10.2217\/fmb-2016-0040","journal-title":"Future Microbiol"},{"key":"7903_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L et al (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009\u20131023. https:\/\/doi.org\/10.1007\/s00134-022-06684-3","journal-title":"Intensive Care Med"},{"key":"7903_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","volume":"47","author":"A Rouze","year":"2021","unstructured":"Rouze A, Martin-Loeches I, Povoa P et al (2021) Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med 47:188\u2013198. https:\/\/doi.org\/10.1007\/s00134-020-06323-9","journal-title":"Intensive Care Med"},{"key":"7903_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020127","author":"LF Reyes","year":"2025","unstructured":"Reyes LF, Torres A, Olivella-Gomez J, Ib\u00e1\u00f1ez-Prada ED, Nseir S, Ranzani OT, Povoa P, Diaz E, Schultz MJ, Rodr\u00edguez AH, Serrano-Mayorga CC, De Pascale G, Navalesi P, Skoczynski S, Esperatti M, Coelho LM, Cortegiani A, Aliberti S, Caricato A, Martin-Loeches I, on behalf of the European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators (2025) Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections: An ENIRRI Analysis. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics14020127","journal-title":"Antibiotics (Basel)"},{"key":"7903_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1473-3099(15)00151-6","volume":"15","author":"Y Shindo","year":"2015","unstructured":"Shindo Y, Ito R, Kobayashi D et al (2015) Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study. Lancet Infect Dis 15:1055\u20131065. https:\/\/doi.org\/10.1016\/S1473-3099(15)00151-6","journal-title":"Lancet Infect Dis"},{"key":"7903_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cmi.2021.12.021","volume":"28","author":"N Saleem","year":"2022","unstructured":"Saleem N, Ryckaert F, Snow TAC et al (2022) Mortality and clinical cure rates for pneumonia: a systematic review, meta-analysis, and trial sequential analysis of randomized control trials comparing bactericidal and bacteriostatic antibiotic treatments. Clin Microbiol Infect 28:936\u2013945. https:\/\/doi.org\/10.1016\/j.cmi.2021.12.021","journal-title":"Clin Microbiol Infect"},{"key":"7903_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.29566","volume":"4","author":"A Dinh","year":"2021","unstructured":"Dinh A, Duran C, Ropers J et al (2021) Factors associated with treatment failure in moderately severe community-acquired pneumonia: a secondary analysis of a randomized clinical trial. JAMA Netw Open 4:e2129566. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.29566","journal-title":"JAMA Netw Open"},{"key":"7903_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","volume":"46","author":"L Papazian","year":"2020","unstructured":"Papazian L, Klompas M, Luyt CE (2020) Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med 46:888\u2013906. https:\/\/doi.org\/10.1007\/s00134-020-05980-0","journal-title":"Intensive Care Med"},{"key":"7903_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cmi.2024.05.017","volume":"30","author":"M Ghadimi","year":"2024","unstructured":"Ghadimi M, Siemieniuk RAC, Guyatt G et al (2024) Empiric antibiotic regimens in adults with non-ventilator-associated hospital-acquired pneumonia: a systematic review and network meta-analysis of randomized controlled trials. Clin Microbiol Infect 30:1351\u20131363. https:\/\/doi.org\/10.1016\/j.cmi.2024.05.017","journal-title":"Clin Microbiol Infect"},{"key":"7903_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.chest.2020.10.039","volume":"159","author":"M Howatt","year":"2021","unstructured":"Howatt M, Klompas M, Kalil AC et al (2021) Carbapenem antibiotics for the empiric treatment of nosocomial pneumonia: a systematic review and meta-analysis. Chest 159:1041\u20131054. https:\/\/doi.org\/10.1016\/j.chest.2020.10.039","journal-title":"Chest"},{"key":"7903_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/s0272-5231(05)70241-0","volume":"20","author":"T Kuru","year":"1999","unstructured":"Kuru T, Lynch JP 3rd (1999) Nonresolving or slowly resolving pneumonia. Clin Chest Med 20:623\u2013651. https:\/\/doi.org\/10.1016\/s0272-5231(05)70241-0","journal-title":"Clin Chest Med"},{"key":"7903_CR37","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/archinte.159.9.970","volume":"159","author":"MJ Fine","year":"1999","unstructured":"Fine MJ, Stone RA, Singer DE et al (1999) Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 159:970\u2013980. https:\/\/doi.org\/10.1001\/archinte.159.9.970","journal-title":"Arch Intern Med"},{"key":"7903_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0272-5231(21)01045-5","volume":"8","author":"AM Fein","year":"1987","unstructured":"Fein AM, Feinsilver SH, Niederman MS et al (1987) When the pneumonia doesn\u2019t get better. Clin Chest Med 8:529\u2013541","journal-title":"Clin Chest Med"},{"issue":"9","key":"7903_CR39","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1378\/chest.09-0258","volume":"39","author":"JU Rello","year":"2011","unstructured":"Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048\u20132058. https:\/\/doi.org\/10.1097\/CCM.0b013e31821e8791","journal-title":"Crit Care Med"},{"key":"7903_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1378\/chest.09-0258","volume":"136","author":"J Rello","year":"2009","unstructured":"Rello J, Lisboa T, Lujan M et al (2009) Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136:832\u2013840. https:\/\/doi.org\/10.1378\/chest.09-0258","journal-title":"Chest"},{"key":"7903_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/bjaed\/mkv052","volume":"16","author":"AJ Morgan","year":"2016","unstructured":"Morgan AJ, Glossop AJ (2016) Severe community-acquired pneumonia. BJA Educ 16:167\u2013172. https:\/\/doi.org\/10.1093\/bjaed\/mkv052","journal-title":"BJA Educ"},{"key":"7903_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz MH, Hammond NE, Brett SJ et al (2024) Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis. JAMA 332:638\u2013648. https:\/\/doi.org\/10.1001\/jama.2024.9803","journal-title":"JAMA"},{"key":"7903_CR43","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/CCM.0b013e3181a3aa43","volume":"37","author":"AC Kalil","year":"2009","unstructured":"Kalil AC, Florescu DF (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 37:2350\u20132358. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a3aa43","journal-title":"Crit Care Med"},{"key":"7903_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s0954-6111(99)90157-9","volume":"93","author":"JA Jacobs","year":"1999","unstructured":"Jacobs JA, De Brauwer EI, Ramsay G et al (1999) Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology. Respir Med 93:571\u2013578. https:\/\/doi.org\/10.1016\/s0954-6111(99)90157-9","journal-title":"Respir Med"},{"key":"7903_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1592\/phco.30.1.57","volume":"30","author":"RA Patel","year":"2010","unstructured":"Patel RA, Gallagher JC (2010) Drug fever. Pharmacotherapy 30:57\u201369. https:\/\/doi.org\/10.1592\/phco.30.1.57","journal-title":"Pharmacotherapy"},{"key":"7903_CR46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.126.4.1274","volume":"126","author":"CY Tu","year":"2004","unstructured":"Tu CY, Hsu WH, Hsia TC et al (2004) Pleural effusions in febrile medical ICU patients: chest ultrasound study. Chest 126:1274\u20131280. https:\/\/doi.org\/10.1378\/chest.126.4.1274","journal-title":"Chest"},{"key":"7903_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MCP.0000000000000567","volume":"25","author":"N Garin","year":"2019","unstructured":"Garin N, Marti C, Scheffler M et al (2019) Computed tomography scan contribution to the diagnosis of community-acquired pneumonia. Curr Opin Pulm Med 25:242\u2013248. https:\/\/doi.org\/10.1097\/MCP.0000000000000567","journal-title":"Curr Opin Pulm Med"},{"key":"7903_CR48","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","volume":"192","author":"YE Claessens","year":"2015","unstructured":"Claessens YE, Debray MP, Tubach F et al (2015) Early Chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med 192:974\u2013982. https:\/\/doi.org\/10.1164\/rccm.201501-0017OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7903_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2214\/ajr.174.6.1741745","volume":"174","author":"N Tomiyama","year":"2000","unstructured":"Tomiyama N, Muller NL, Johkoh T et al (2000) Acute parenchymal lung disease in immunocompetent patients: diagnostic accuracy of high-resolution CT. AJR Am J Roentgenol 174:1745\u20131750. https:\/\/doi.org\/10.2214\/ajr.174.6.1741745","journal-title":"AJR Am J Roentgenol"},{"key":"7903_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12879-023-08255-3","volume":"23","author":"RF Dias","year":"2023","unstructured":"Dias RF, de Paula A, Hasparyk UG et al (2023) Use of C-reactive protein to guide the antibiotic therapy in hospitalized patients: a systematic review and meta-analysis. BMC Infect Dis 23:276. https:\/\/doi.org\/10.1186\/s12879-023-08255-3","journal-title":"BMC Infect Dis"},{"key":"7903_CR51","doi-asserted-by":"publisher","first-page":"CD007498","DOI":"10.1002\/14651858.CD007498.pub3","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R et al (2017) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 10:CD007498. https:\/\/doi.org\/10.1002\/14651858.CD007498.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"7903_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.idc.2012.11.009","volume":"27","author":"S Sialer","year":"2013","unstructured":"Sialer S, Liapikou A, Torres A (2013) What is the best approach to the nonresponding patient with community-acquired pneumonia? Infect Dis Clin North Am 27:189\u2013203. https:\/\/doi.org\/10.1016\/j.idc.2012.11.009","journal-title":"Infect Dis Clin North Am"},{"key":"7903_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210520","volume":"14","author":"MJ Choi","year":"2019","unstructured":"Choi MJ, Noh JY, Cheong HJ et al (2019) Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS ONE 14:e0210520. https:\/\/doi.org\/10.1371\/journal.pone.0210520","journal-title":"PLoS ONE"},{"key":"7903_CR54","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jmii.2016.12.004","volume":"51","author":"HY Lee","year":"2018","unstructured":"Lee HY, Wu TL, Su LH et al (2018) Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan. J Microbiol Immunol Infect 51:500\u2013509. https:\/\/doi.org\/10.1016\/j.jmii.2016.12.004","journal-title":"J Microbiol Immunol Infect"},{"key":"7903_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","author":"PD Tamma","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA et al (2024) Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"7903_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/ice.2017.308","volume":"39","author":"D Chotiprasitsakul","year":"2018","unstructured":"Chotiprasitsakul D, Tamma PD, Gadala A et al (2018) The role of negative methicillin-resistant staphylococcus aureus nasal surveillance swabs in predicting the need for empiric vancomycin therapy in intensive care unit patients. Infect Control Hosp Epidemiol 39:290\u2013296. https:\/\/doi.org\/10.1017\/ice.2017.308","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7903_CR57","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/MCC.0000000000001187","volume":"30","author":"CJ Dyer","year":"2024","unstructured":"Dyer CJ, De Waele JJ, Roberts JA (2024) Antibiotic dose optimisation in the critically ill: targets, evidence and future strategies. Curr Opin Crit Care 30:439\u2013447. https:\/\/doi.org\/10.1097\/MCC.0000000000001187","journal-title":"Curr Opin Crit Care"},{"key":"7903_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","volume":"48","author":"S Hagel","year":"2022","unstructured":"Hagel S, Bach F, Brenner T et al (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med 48:311\u2013321. https:\/\/doi.org\/10.1007\/s00134-021-06609-6","journal-title":"Intensive Care Med"},{"key":"7903_CR59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ et al (2024) Continuous vs Intermittent beta-lactam antibiotic infusions in critically Ill patients with sepsis: the BLING III randomized clinical trial. JAMA 332:629\u2013637. https:\/\/doi.org\/10.1001\/jama.2024.9779","journal-title":"JAMA"},{"key":"7903_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18234","volume":"7","author":"SM Karaba","year":"2024","unstructured":"Karaba SM, Cosgrove SE, Lee JH et al (2024) Extended-infusion beta-lactam therapy, mortality, and subsequent antibiotic resistance among hospitalized adults with gram-negative bloodstream infections. JAMA Netw Open 7:e2418234. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.18234","journal-title":"JAMA Netw Open"},{"key":"7903_CR61","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00134-024-07529-x","volume":"50","author":"LS Boers","year":"2024","unstructured":"Boers LS, van Someren GF, van Hattem JM et al (2024) Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19. Intensive Care Med 50:1251\u20131264. https:\/\/doi.org\/10.1007\/s00134-024-07529-x","journal-title":"Intensive Care Med"},{"key":"7903_CR62","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00134-024-07562-w","volume":"50","author":"CE Luyt","year":"2024","unstructured":"Luyt CE, Girardis M, Paixao P (2024) Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question. Intensive Care Med 50:1317\u20131319. https:\/\/doi.org\/10.1007\/s00134-024-07562-w","journal-title":"Intensive Care Med"},{"key":"7903_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","volume":"162","author":"N Singh","year":"2000","unstructured":"Singh N, Rogers P, Atwood CW et al (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505\u2013511. https:\/\/doi.org\/10.1164\/ajrccm.162.2.9909095","journal-title":"Am J Respir Crit Care Med"},{"key":"7903_CR64","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cid\/ciw870","volume":"64","author":"M Klompas","year":"2017","unstructured":"Klompas M, Li L, Menchaca JT et al (2017) Ultra-short-course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis 64:870\u2013876. https:\/\/doi.org\/10.1093\/cid\/ciw870","journal-title":"Clin Infect Dis"},{"key":"7903_CR65","doi-asserted-by":"publisher","DOI":"10.62675\/2965-2774.20240017-en","volume":"36","author":"P Moniz","year":"2024","unstructured":"Moniz P, Fustiga J, Herculano MM et al (2024) Optimization of antibiotic use in the intensive care unit: how we do it. Crit Care Sci 36:e20240017en. https:\/\/doi.org\/10.62675\/2965-2774.20240017-en","journal-title":"Crit Care Sci"},{"key":"7903_CR66","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmi.2021.10.022","volume":"28","author":"J Curran","year":"2022","unstructured":"Curran J, Lo J, Leung V et al (2022) Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis. Clin Microbiol Infect 28:479\u2013490. https:\/\/doi.org\/10.1016\/j.cmi.2021.10.022","journal-title":"Clin Microbiol Infect"}],"updated-by":[{"DOI":"10.1007\/s00134-025-08027-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-07903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-07903-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-07903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:40:48Z","timestamp":1757173248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-07903-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7903"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-07903-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00134-025-08027-4","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the finalization of the manuscript, a areference was erroneously omitted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00134-025-08027-4","URL":"https:\/\/doi.org\/10.1007\/s00134-025-08027-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PP received fees for lecture from Gilead and Mundipharma, consulting from MSD and Biocodex. KC received fees for lectures and advisory board from BD. RF received fees as speaker and\/or advisor for Pfizer, MSD, Shionogi, Gilead, GE, AOP Health, Grifols, Thermofisher, Estor, Toray, BD, Menarini, Viatris. CAG received consultation fees from Karius Inc Diagnostics. MK has grants from CDC, AHRQ; contracts from Massachusetts Department of Public Health; royalties from UpToDate. IML received fees lectures and advisory board MSD, Menarini, Biomerieux, Mundipharma, Gilead, and Thermofisher. SN received consultation fees from Mundipharma, and lecture fees from MSD, Biom\u00e9rieux, Pfizer, Fisher and Peykel, Shionogi, and Medtronic. LC, JC, SEC, TL, JIFS, SS, DS, AK declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}